Literature DB >> 12362411

Axonal neuropathy in chronic peripheral arterial occlusive disease.

Frank Weber1, Andrea Ziegler.   

Abstract

Chronic peripheral arterial occlusive disease of the lower limbs may cause tissue damage. Type and extent of peripheral nerve involvement is controversial. We examined 25 patients with peripheral arterial occlusive disease in various grades of severity and 37 age-matched healthy controls using conventional angiography and motor and sensory nerve conduction tests. Subjects with confounding factors for peripheral neuropathies were excluded. We found prolongation of distal motor latencies, decrease of motor and sensory nerve conduction velocities, and reduction in amplitude of the compound muscle action potential. Amplitudes of the compound muscle action potentials were lower in patients with pain at rest than in patients with intermittent claudication and decreased with increasing neurological disability score. Sural nerve conduction velocity, peroneal nerve F-wave chronodispersion, and tibial nerve F-wave persistence were the most frequent abnormal findings. Therefore we concluded that chronic peripheral arterial occlusive disease causes axonal degeneration, resulting in axonal polyneuropathy. Copyright 2002 Wiley Periodicals, Inc. Muscle Nerve 26: 471-476, 2002

Entities:  

Mesh:

Year:  2002        PMID: 12362411     DOI: 10.1002/mus.10235

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  15 in total

1.  Pharmacological treatment of intermittent claudication does not have a significant effect on gait impairments during claudication pain.

Authors:  Jennifer M Yentes; Jessie M Huisinga; Sara A Myers; Iraklis I Pipinos; Jason M Johanning; Nicholas Stergiou
Journal:  J Appl Biomech       Date:  2012-05       Impact factor: 1.833

2.  [Painful ischemic neuropathy].

Authors:  P M Lang
Journal:  Nervenarzt       Date:  2015-02       Impact factor: 1.214

Review 3.  Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia.

Authors:  Mary McGrae McDermott
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

4.  Vascular occlusion affects gait variability patterns of healthy younger and older individuals.

Authors:  Sara A Myers; Jason M Johanning; Iraklis I Pipinos; Kendra K Schmid; Nicholas Stergiou
Journal:  Ann Biomed Eng       Date:  2012-10-09       Impact factor: 3.934

5.  Lower extremity nerve function in patients with lower extremity ischemia.

Authors:  Mary M McDermott; Robert Sufit; Takashi Nishida; Jack M Guralnik; Luigi Ferrucci; Lu Tian; Kiang Liu; Jin Tan; William H Pearce; Joseph R Schneider; Leena Sharma; Michael H Criqui
Journal:  Arch Intern Med       Date:  2006-10-09

6.  Gait variability of patients with intermittent claudication is similar before and after the onset of claudication pain.

Authors:  Sara A Myers; Iraklis I Pipinos; Jason M Johanning; Nicholas Stergiou
Journal:  Clin Biomech (Bristol, Avon)       Date:  2011-03-29       Impact factor: 2.063

7.  Muscle strength and control characteristics are altered by peripheral artery disease.

Authors:  Molly N Schieber; Ryan M Hasenkamp; Iraklis I Pipinos; Jason M Johanning; Nicholas Stergiou; Holly K DeSpiegelaere; Jung H Chien; Sara A Myers
Journal:  J Vasc Surg       Date:  2017-07       Impact factor: 4.268

8.  Joint torques and powers are reduced during ambulation for both limbs in patients with unilateral claudication.

Authors:  Panagiotis Koutakis; Iraklis I Pipinos; Sara A Myers; Nicholas Stergiou; Thomas G Lynch; Jason M Johanning
Journal:  J Vasc Surg       Date:  2009-10-17       Impact factor: 4.268

9.  [Therapy of chronic ischemic pain in peripheral arterial disease. A survey among physicians].

Authors:  L J Rüger; D Irnich; S Grasmueller; P M Lang
Journal:  Schmerz       Date:  2008-04       Impact factor: 1.107

10.  Gait kinematics and kinetics are affected more by peripheral arterial disease than by age.

Authors:  Sara A Myers; Bryon C Applequist; Jessie M Huisinga; Iraklis I Pipinos; Jason M Johanning
Journal:  J Rehabil Res Dev       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.